Literature DB >> 23503770

In vivo oxymetric analysis of mild hypercapnia upon cerebral oxygen, temperature and blood flow: markers of mood as proposed by concomitant bupropion challenge and electrochemical analysis?

Francesco Crespi1.   

Abstract

Scientific interest has increased the influence of temperature in neurodegenerative and psychiatric disorders, and according to the monoamine hypothesis, depression is a neurochemical disorder arising from hypofunctioning of brain monoamine systems. Here, in vivo flow-oxymetry is applied to verify relationships between cerebral oxygen tension (pO2), blood flow (CBF), that are markers of brain metabolism, and temperature (T), while in vivo voltammetry is concomitantly applied in the medial prefrontal cortex of anaesthetized rats to monitor monoamine levels such as dopamine (DA) and serotonin. An induced mild hypercapnia via increasing exogenous carbon dioxide (CO2) concentration resulted in increased pO2, CBF and T in discrete brain areas. Concomitant in situ voltammetric analysis of extracellular levels of serotonin and DA has revealed significant changes in the latter, only. Parallel treatment with antidepressant bupropion has confirmed its described central thermogenic properties and its positive influence on dopaminergic activity. CBF was also enhanced by such antidepressant. Altogether these data support direct relationships between markers of brain metabolism such as pO2, CBF, T and brain monoamine[s], indicating the coupled in vivo methodology: oxymetry-voltammetry as a rapid in vivo tool for analyses of such indicators in psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23503770     DOI: 10.1007/s00221-013-3443-2

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  35 in total

1.  Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain.

Authors:  P A SHORE; S L SILVER; B B BRODIE
Journal:  Science       Date:  1955-08-12       Impact factor: 47.728

2.  THE EFFECTS OF ALTERED ARTERIAL TENSIONS OF CARBON DIOXIDE AND OXYGEN ON CEREBRAL BLOOD FLOW AND CEREBRAL OXYGEN CONSUMPTION OF NORMAL YOUNG MEN.

Authors:  S S Kety; C F Schmidt
Journal:  J Clin Invest       Date:  1948-07       Impact factor: 14.808

3.  Thermodynamic laws apply to brain function.

Authors:  Alen J Salerian
Journal:  Med Hypotheses       Date:  2009-10-02       Impact factor: 1.538

Review 4.  Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review.

Authors:  N Bonhomme; E Esposito
Journal:  J Clin Psychopharmacol       Date:  1998-12       Impact factor: 3.153

Review 5.  Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.

Authors:  S M Stahl
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

6.  Cerebral circulatory response to hypercapnia: effects of lesions of central dopaminergic and serotoninergic neuron systems.

Authors:  N Dahlgren; O Lindvall; A Nobin; U Stenevi
Journal:  Brain Res       Date:  1981-12-28       Impact factor: 3.252

7.  Delirious behavior in children with influenza: its clinical features and EEG findings.

Authors:  Akihisa Okumura; Takashi Nakano; Yukiko Fukumoto; Kazuo Higuchi; Hitoshi Kamiya; Kazuyoshi Watanabe; Tsuneo Morishima
Journal:  Brain Dev       Date:  2005-06       Impact factor: 1.961

8.  Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model.

Authors:  Ming Ren; Vladimir V Senatorov; Ren-Wu Chen; De-Maw Chuang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

9.  Screening of drugs for thermogenic anti-obesity properties: antidepressants.

Authors:  A G Dulloo; D S Miller
Journal:  Ann Nutr Metab       Date:  1987       Impact factor: 3.374

10.  Chronic treatment with antidepressants decreases intraoperative core hypothermia.

Authors:  Akira Kudoh; Hajime Takase; Tomoko Takazawa
Journal:  Anesth Analg       Date:  2003-07       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.